cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - agenti antineoplastici - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
institute esthederm intolerances solaires crema lenitiva e protettiva 50ml
institut esthederm italia div. -
institut esthederm huile solaire 3 soleil extreme olio secco protezione solare 150ml
institut esthederm italia div. -
institut esthederm huile solaire 2 soleil normal ou fort 150ml
institut esthederm italia div. -
institut esthederm uv incellium trattamento protezione uva-uvb spray 100ml
institut esthederm italia div. -
institut esthederm bronz repair soleil fort protezione solare forte antirughe 50ml
institut esthederm italia div. -
institut esthederm bronz repair soleil modere crema solare protezione media antirughe 50ml
institut esthederm italia div. -
institut esthederm adaptasun lait corps soleil modéré protezione solare corpo 200ml
institut esthederm italia div. -
institut esthederm adaptasun lait corps soleil fort protezione solare corpo 200ml
institut esthederm italia div. -
institut esthederm repair apres soleil doposole antirughe 50ml
institut esthederm italia div. -